IVTY Invuity Inc

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Invuity, Inc., and Encourages Investors with Losses to Contact the Firm

Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against Invuity, Inc. (“Invuity” or the “Company”) (Nasdaq: IVTY). Investors who purchased or otherwise acquired Invuity shares between July 19, 2016, and November 3, 2016, inclusive (the “Class Period”), are encouraged to contact the firm in advance of the April 28, 2017 lead plaintiff deadline.

If you purchased shares of Invuity during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at [email protected].

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

On November 3, 2016, Invuity announced its financial results for the third quarter of 2016 and, recognizing in part a decrease in average revenue per account, the Company lowered its guidance.

When this information was announced to the investing public, Invuity stock dropped, causing investors harm.

If you wish to learn more about this lawsuit at no charge, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at [email protected].

This press release may constitute Attorney Advertising in some jurisdictions.

EN
08/03/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Invuity Inc

 PRESS RELEASE

Invuity Announces Definitive Agreement to Be Acquired by Stryker Corpo...

Invuity Announces Definitive Agreement to Be Acquired by Stryker Corporation for $7.40 Per Share in Cash SAN FRANCISCO, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY), a leading medical technology company focused on advanced surgical devices to enable better visualization, today announced it has entered into a definitive agreement with Stryker Corporation (NYSE:SYK), pursuant to which Stryker will acquire all of the outstanding shares of Invuity for $7.40 per share in cash, implying a total equity value of approximately $190 million. "The combination of Stryker's establi...

 PRESS RELEASE

Invuity Announces Commercial Launch of PhotonGuide® Adapt for Vaginal...

Invuity Announces Commercial Launch of PhotonGuide® Adapt for Vaginal Hysterectomy and Pelvic Organ Prolapse Procedures SAN FRANCISCO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced the full commercial launch of PhotonGuide® Adapt, a novel system that consists of a flexible illuminator and a family of compatible retractors for surgical procedures performed vaginally including pelvic organ prolapse repairs and vaginal hysterectomies. PhotonGuide Adapt represents a new platform for Invui...

 PRESS RELEASE

Invuity Announces 2018 Second Quarter, Six-Month Financial Results

Invuity Announces 2018 Second Quarter, Six-Month Financial Results SAN FRANCISCO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced financial results for the second quarter and six months ended June 30, 2018. Q2 2018 Highlights Second quarter 2018 revenue grew 7.5% to $10.5 million compared to revenue of $9.8 million in the second quarter of 2017.Disposable revenue in the second quarter of 2018 grew 11.5% to $9.2 million compared to $8.3 million in the second quarter of 2017.Net loss for the second q...

 PRESS RELEASE

Invuity Announces 2018 Second Quarter Financial Results and Conference...

Invuity Announces 2018 Second Quarter Financial Results and Conference Call Date SAN FRANCISCO, July 20, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that it will release its 2018 second quarter financial results after the market closes on Thursday, August 2, 2018. In conjunction with the release, the Company will host a conference call with the investment community at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on Thursday, August 2, 2018, to discuss the financial results and other busine...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch